Yang L, Du Z, Peng Y, Zhang W, Feng W, Yuan Y.  Mebendazole effectively overcomes imatinib resistance by dual-targeting BCR/ABL oncoprotein and β-tubulin in chronic myeloid leukemia cells.  Korean J Physiol Pharmacol 2025;29:67-81.  https://doi.org/10.4196/kjpp.24.176